Glycosphingolipid Levels in Urine Extracellular Vesicles Enhance Prediction of Therapeutic Response in Lupus Nephritis

The development of nephritis increases the risk of morbidity and mortality in systemic lupus erythematosus (SLE) patients. While standard induction therapies, such as mycophenolate mofetil (MMF) induce clinical remission (i.e., complete response) in approximately 50% of SLE patients with nephritis,...

Full description

Bibliographic Details
Published in:	Metabolites
Main Authors:	Brian Troyer, Jessalyn Rodgers, Bethany J. Wolf, James C. Oates, Richard R. Drake, Tamara K. Nowling
Format:	Article
Language:	English
Published:	MDPI AG 2022-02-01
Subjects:	lupus nephritis biomarker glycosphingolipid extracellular vesicle
Online Access:	https://www.mdpi.com/2218-1989/12/2/134

Similar Items

The role of neuraminidase 1 (NEU1) in cytokine release by primary mouse mesangial cells and disease outcomes in murine lupus nephritis
by: Jessalyn Rodgers, et al.
Published: (2021-04-01)

Urine Extracellular Vesicles Size Subsets as Lupus Nephritis Biomarkers
by: Itze C. Navarro-Hernandez, et al.
Published: (2024-10-01)

Podocyte extracellular vesicles and immune mediators as urinary biomarkers in active lupus nephritis
by: Lilian Alves, et al.
Published: (2025-08-01)

Clinical significance of urine hepcidin in lupus nephritis
by: TANG Dai-rong, et al.
Published: (2017-01-01)

Tubulointerstitial lupus nephritis
by: Ala Ali, et al.
Published: (2013-01-01)

Mesenchymal stem cells-derived extracellular vesicles ameliorate lupus nephritis by regulating T and B cell responses
by: Cuifang Li, et al.
Published: (2024-07-01)

Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis
by: Muhammed Mubarak
Published: (2013-01-01)

The Role of Extracellular Vesicles in Systemic Lupus Erythematosus
by: Chenghui Zheng, et al.
Published: (2022-03-01)

Urine and serum interleukin 35 as potential biomarkers of lupus nephritis
by: Mary Atef Nassif
Published: (2021-10-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

The Clinicopathological Study of Lupus Nephritis
by: Raouf Rahim Merza, et al.
Published: (2014-08-01)

Lupus Nephritis and Dysbiosis
by: Marta Monticolo, et al.
Published: (2023-04-01)

MiR-1290 in natural killer cell derived extracellular vesicles: a pathogenic mediator of lupus nephritis and therapeutic target for th17 regulation
by: Chen Cheng, et al.
Published: (2026-03-01)

Neutrophil gelatinase-associated lipocalin is a urine-based biomarker for diagnosing active lupus nephritis
by: Anthony Chakma, et al.
Published: (2025-04-01)

Current and Emerging Therapy on Lupus Nephritis
by: Lucky Aziza Bawazier
Published: (2018-01-01)

Lupus Nephritis, the therapy and the role of Rituximab in resistant cases
by: Hussein A. Nasir, et al.
Published: (2014-01-01)

Correlation between dyslipidemia and disease activity of lupus nephritis
by: Hu Hong-tu, et al.
Published: (2021-01-01)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
by: Marlene Plüß, et al.
Published: (2022-11-01)

Lupus nephritis – modern aspects of diagnosis and therapy. Part I
by: S. K. Solovyev, et al.
Published: (2024-03-01)

Lupus nephritis in the XXI century
by: Irina N. Bobkova, et al.
Published: (2022-08-01)

Lupus nephritis and thrombotic microangiopathy: A review
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)

Immunophenotyping identifies distinct cellular signatures for systemic lupus erythematosus and lupus nephritis
by: Yi Tong V. Aw, et al.
Published: (2023-03-01)

Literature review and case study of predominant tubulointerstitial lupus nephritis
by: Jun Wang, et al.
Published: (2025-12-01)

Management of Lupus Nephritis
by: Merkel F, et al.
Published: (2000-01-01)

Pediatric lupus nephritis
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2018-11-01)

Bioinformatics analysis of gene expression microarray in lupus nephritis
by: JIANG Qiu-zhu, et al.
Published: (2020-01-01)

Expression and clinical significance of NGAL/NGALR in lupus nephritis
by: ZENG Xing-ruo, et al.
Published: (2017-01-01)

Experience using low doses of calcineurin inhibitors in the treatment of refractory lupus nephritis
by: César Augusto Restrepo Valencia, et al.
Published: (2014-10-01)

Evaluation of Treatment Response in Lupus Nephritis
by: Anca BOBIRCA, et al.
Published: (2021-12-01)

Tim-1 alleviates lupus nephritis-induced podocyte injury via regulating autophagy
by: Yunxia Yu, et al.
Published: (2021-10-01)

Lupus nephritis. Part II, modern ideas about therapy
by: Elena A. Aseeva, et al.
Published: (2024-09-01)

Biomarkers in biological fluids and their potential use as indicators of lupus nephritis in individuals with systemic lupus erythematous
by: Lisandro Pacheco-Lugo, et al.
Published: (2014-05-01)

Lupus Nephritis, Pauci Immune Rapidly Progressive Glomerolu Nephritis: Case Report
by: Naser Saeidi, et al.
Published: (2018-02-01)

Lupus nephritis in Bangladesh: unfolding the story
by: Mubarak Muhammed
Published: (2016-01-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

Long-term prognosis of lupus nephritis: comparison between pediatric, adult, and advanced age onset
by: Marta Calatroni, et al.
Published: (2025-03-01)

Urinary CXCL10: a marker of nephritis in lupus patients
by: M. A. Marie, et al.
Published: (2014-03-01)

NETosis in lupus nephritis
by: Tatiana M. Reshetnyak, et al.
Published: (2024-06-01)

Glycosphingolipids as emerging attack points in bladder cancer
by: Inês B. Moreira, et al.
Published: (2025-04-01)

Glycosphingolipids in human parasites
by: Richard D. Cummings
Published: (2023-09-01)